Gustavo de Souza Portes Meirelles

Gustavo de Souza Portes Meirelles

Auto-generated profile, based on publicly available information

Gustavo de Souza Portes Meirelles

Grupo Fleury, Brazil

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Respiratory Medicine
Verified
Journal Article
Closed access
SJSérgio Ferreira Alves Júnior
Sérgio Ferreira Alves Júnior
GZGláucia Zanetti
Gláucia Zanetti
AMAlessandro Severo Alves de Melo
Alessandro Severo Alves de Melo
Arthur Soares Souza JúniorArthur Soares Souza Júnior
Arthur Soares Souza Júnior
LSLuciana Soares Souza
Luciana Soares Souza
EMEdson Santos Marchiori
Edson Santos Marchiori

1 February 2011 in Journal of Thoracic Imaging
Verified
Journal Article
Closed access
GMGustavo Souza Portes Meirelles
Gustavo Souza Portes Meirelles
MGMithat Gonen
Mithat Gonen
HSHarry William Strauss
Harry William Strauss
Purpose Vascular 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) uptake has been suggested as a means of identifying metabolically active atheroma, whereas vascular calcification is accepted as an indicator of atherosclerosis. This investigation describes the frequency and stability of 18F-FDG uptake and vascular calcification in the thoracic aorta on serial 18F-FDG positron emission tomography/computed tomography (PET/CT) studies and correlates the findings with clinical data and risk factors for cardiovascular disease (CVD). Materials and Methods Serial 18F-FDG-PET/CT scans of 100 cancer patients who had at least 2 PET/CT studies were reviewed. Sites of aortic 18F-FDG uptake and calcifications were identified. Results were compared to assess the frequency and stability of the vascular findings and their correlation with clinical data. Results 18F-FDG aortic uptake was seen in 70% of the patients on the initial scan and changed on the second scan in 55% of the patients. Calcifications were often seen in patients with 18F-FDG uptake, but calcification and 18F-FDG uptake were present at the same site in only 2 cases. Both calcification and 18F-FDG uptake correlated with age. Patients with diabetes, hypertension, hyperlipidemia, or a history of CVD had significantly more calcifications. No correlation was seen between 18F-FDG uptake and calcification stability and the interval between scans, age, risk factors, or history of CVD. Conclusions 18F-FDG vascular uptake was common on PET/CT and correlated with vascular calcifications, although the specific sites rarely overlapped. Calcifications were stable over time, but 18F-FDG uptake changed in more than half of the patients, supporting the postulate that inflammation in atheroma is a waxing and waning inflammatory process.

1 October 2020 in Radiologia Brasileira
Verified
Journal Article
Open access
PDF file
GMGustavo de Souza Portes Meirelles
Gustavo de Souza Portes Meirelles
Coronavirus disease 2019 (COVID-19), which is caused by a new coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-is a pandemic with major impacts on the health care sector, and a broad view of the disease is of fundamental importance for any radiologist. The purpose of this review is to address the main clinical and imaging aspects of COVID-19, as well as guidelines for requesting and using imaging methods; measures to protect patients and health care professionals; systems for quantifying pulmonary findings and preparing integrated reports; and the main innovations that have emerged during this pandemic.

1 June 2020 in Radiologia Brasileira
Verified
Journal Article
Open access
PDF file
GBGabriela Irene Garcia Brandes
Gabriela Irene Garcia Brandes
GDGiuseppe D’iPpolito
Giuseppe D’iPpolito
AAAnderson Gusatti Azzolini
Anderson Gusatti Azzolini
GMGustavo Meirelles
Gustavo Meirelles
Objective: To evaluate the impact of artificial intelligence (AI) on undergraduate medical students’ choice of radiology as a specialty. Materials and Methods: In February 2019, an anonymous online survey was sent to medical students. The research contemplated questions on how much students think they know about AI technologies, how much AI discourages them from choosing radiology as a specialty, and whether they believe there is a threat to the radiology job market. Results: A total of 101 students, most of them doing their internship, answered the questionnaire. More than half of them (52.5%) said they believe AI poses a threat to the radiology job market, but 64.3% claimed not to have proper knowledge about these new technologies, and 31.7% said they would like more information on the technologies’ operation and progress before making a decision on whether or not to practice radiology as a specialty. Conclusion: A significant proportion of the surveyed students perceive AI as a threat to the radiological practice, which impacts their career choice. However, the majority claims to have insufficient knowledge of it and believes more information is needed for decision-making.

18 June 2021 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PTPedro Paulo Teixeira e Silva Torres
Pedro Paulo Teixeira e Silva Torres
MRMarcelo Fouad Rabahi
Marcelo Fouad Rabahi
MMMaria Auxiliadora do Carmo Moreira
Maria Auxiliadora do Carmo Moreira
DEDante Luiz Escuissato
Dante Luiz Escuissato
GMGustavo de Souza Portes Meirelles
Gustavo de Souza Portes Meirelles
EMEdson Santos Marchiori
Edson Santos Marchiori
Many conditions result in chronic interstitial lung disease (ILD), being classified as fibrosing ILDs, including idiopathic pulmonary fibrosis, connective tissue diseases, sarcoidosis, and fibrotic hypersensitivity pneumonitis. HRCT plays an important role in the clinical evaluation of fibrosing ILDs. Current treatment perspectives are encouraging and reinforce the need for HRCT scans of adequate technical quality for early detection of fibrosing ILD. Despite efforts in this regard, the significance and management of imaging findings of early interstitial lung abnormalities have yet to be clarified. After identification of CT findings consistent with fibrosing ILD, radiologists must be able to identify characteristic morphological patterns and, in some cases, features of specific clinical entities. In cases in which HRCT features are not sufficiently specific for a definitive diagnosis, HRCT can aid in selecting the best site for surgical lung biopsy. CT follow-up is useful for identifying progressive fibrosing ILDs and detecting complications unrelated to the underlying disease, including infections, acute exacerbations, and neoplasms. Automated quantification tools have clinical applicability and are likely to be available for use in imaging analysis in the near future. In addition, incorporation of CT evaluation into scoring systems based on clinical and functional parameters for staging fibrosing disease is likely to become valuable in determining prognosis. Knowledge of the clinical applications of CT evaluation is essential for specialists managing patients with fibrosing ILD and can have a positive impact on the clinical course of the disease.

9 December 2020 in British Journal of Radiology
Verified
Journal Article
Closed access
BHBruno Hochhegger
Bruno Hochhegger
MZMatheus Zanon
Matheus Zanon
SAStephan Altmayer
Stephan Altmayer
NMNicole S Mandelli
Nicole S Mandelli
GSGuilherme Stüker
Guilherme Stüker
EMEdson Santos Marchiori
Edson Santos Marchiori
Chest imaging is often used as a complementary tool in the evaluation of coronavirus disease 2019 (COVID-19) patients, helping physicians to augment their clinical suspicion. Despite not being diagnostic for COVID-19, chest CT may help clinicians to isolate high suspicion patients with suggestive imaging findings. However, COVID-19 findings on CT are also common to other pulmonary infections and non-infectious diseases, and radiologists and point-of-care physicians should be aware of possible mimickers. This state-of-the-art review goal is to summarize and illustrate possible etiologies that may have a similar pattern on chest CT as COVID-19. The review encompasses both infectious etiologies, such as non-COVID viral pneumonia, Mycoplasma pneumoniae, Pneumocystis jiroveci, and pulmonary granulomatous infectious, and non-infectious disorders, such as pulmonary embolism, fat embolism, cryptogenic organizing pneumonia, non-specific interstitial pneumonia, desquamative interstitial pneumonia, and acute and chronic eosinophilic pneumonia.